It binds the ATP-binding pocket of the p110 subunit of PI3K and to the catalytic site of mTOR, so it is able to inhibit both mTORC complexes (mTORC1 and mTORC2), resulting in effective inhibition of tumor proliferation and growth [22,23,24]. Here, MTOR is linked to neoplasm.